Patterns of anti-malarial drug treatment among pregnant women in Uganda

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Sangaré, Laura R ^a   Weiss, Noel S ^a   Brentlinger, Paula E ^a   Richardson, Barbra A ^a   Staedke, Sarah G ^b,c   Kiwuwa, Mpungu S ^d   Stergachis, Andy ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c INFECTIOUS DISEASES RESEARCH COLLABORATION   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; CHLOROQUINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ADULT; ARTICLE; BED NET; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PREGNANCY; PREGNANT WOMAN; SELF REPORT; STILLBIRTH; UGANDA; ADOLESCENT; DRUG COMBINATION; INTERVIEW; MIDDLE AGED; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; STATISTICS;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; ETHANOLAMINES; FEMALE; FLUORENES; GUIDELINE ADHERENCE; HUMANS; INTERVIEWS AS TOPIC; MALARIA; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UGANDA; YOUNG ADULT;

EID: 79957917061     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-152     Document Type: Article

References (52)

1. Epidemiology and burden of malaria in pregnancy. M Desai FO ter Kuile F Nosten R McGready K Asamoa B Brabin RD Newman, Lancet Infect Dis 2007 7 93 104 10.1016/S1473-3099(07)70021-X 17251080 (Pubitemid 46123132)
2. Malaria in pregnancy: priorities for research. B Greenwood P Alonso FO ter Kuile J Hill RW Steketee, Lancet Infect Dis 2007 7 169 174 10.1016/S1473-3099(07)70028-2 17251087 (Pubitemid 46137948)
3. Malaria during pregnancy: a priority area of malaria research and control. C Menendez, Parasitol Today 1995 11 178 183 10.1016/0169-4758(95)80151- 0 15275350
4. Malaria during pregnancy. C Menendez, CurrMolMed 2006 6 269 273
5. World Health Organization, Guidelines for the treatment of malaria Geneva, Switzerland 2 2010
6. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. RL Clark TE White AC S I Gaunt P Winstanley SA Ward, Birth Defects Res B Dev Reprod Toxicol 2004 71 380 394 10.1002/bdrb.20027 15617018 (Pubitemid 40076263)
7. Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. M Longo S Zanoncelli D Manera M Brughera P Colombo J Lansen G Mazue M Gomes WR Taylor P Olliaro, Reprod Toxicol 2006 21 83 93 10.1016/j.reprotox.2005. 05.005 16026965 (Pubitemid 43048778)
8. Sensitive periods for developmental toxicity of orally administered artesunate in the rat. TE White RL Clark, Birth Defects Res B Dev Reprod Toxicol 2008 83 407 417 10.1002/bdrb.20157 18615704
9. Antimalarial drugs in pregnancy: A review. F Nosten R McGready U d'Alessandro A Bonell F Verhoeff C Menendez T Mutabingwa B Brabin, Current Drug Safety 2006 1 1 15 10.2174/157488606775252584 18690910
10. Treatment and prevention of malaria in pregnancy and newborn. O Coll C Menendez F Botet R Dayal X Carbonell-Estrany LE Weisman MM Anceschi A Greenough RS Gibss Y Ville, J Perinat Med 2008 36 15 29 10.1515/JPM.2008.002 18184095
11. The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy. R McGready KL Thwai T Cho S Looareesuwan NJ White F Nosten, Trans R Soc Trop Med Hyg 2002 96 180 184 10.1016/S0035-9203(02)90297-X 12055810 (Pubitemid 34846564)
12. Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy? A Yeka J Achan U D'Alessandro AO Talisuna, Lancet Infect Dis 2009 9 448 452 10.1016/S1473-3099(09)70109-4 19555904
13. The public health impact of chloroquine resistance in Africa. JF Trape, Am J Trop Med Hyg 2001 64 12 17 11425173
14. Conquering the intolerable burden of malaria: what's new, what's needed: a summary. JG Breman MS Alilio A Mills, Am J Trop Med Hyg 2004 71 1 15 15516653 (Pubitemid 39127486)
15. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. SA Ward EJ Sevene IM Hastings F Nosten R McGready, Lancet Infect Dis 2007 7 136 144 10.1016/S1473-3099(07)70025-7 17251084 (Pubitemid 46123134)
16. President's Malaria Initiative, Uganda Malaria Operational Plan (MOP). FY 2010
17. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. PM Newman H Wanzira G Tumwine E Arinaitwe S Waldman J Achan D Havlir PJ Rosenthal G Dorsey TD Clark D Cohan, Malar J 2009 8 254 10.1186/1475-2875-8-254 19912657
18. Management of uncomplicated malaria: A practical guide for health workers. Republic of Uganda, Malaria Control Programme, Ministry of Health 3 2005
19. Symptom overlap for malaria and pneumonia - policy implications for home management strategies. K Kallander J Nsungwa-Sabiiti S Peterson, Acta Trop 2004 90 211 214 10.1016/j.actatropica.2003.11.013 15177148 (Pubitemid 38283771)
20. Use of clinical algorithms for diagnosing malaria. D Chandramohan S Jaffar B Greenwood, Trop Med Int Health 2002 7 45 52 10.1046/j.1365-3156.2002. 00827.x 11851954 (Pubitemid 34131810)
21. Clinical algorithms for malaria diagnosis lack utility among people of different age groups. TW Mwangi M Mohammed H Dayo RW Snow K Marsh, Trop Med Int Health 2005 10 530 536 10.1111/j.1365-3156.2005.01439.x 15941415 (Pubitemid 40806658)
22. The challenges of diagnosis and treatment of malaria in pregnancy in low resource settings. LO Omo-Aghoja E Abe P Feyi-Waboso FE Okonofua, Acta Obstet Gynecol Scand 2008 87 693 696 10.1080/00016340802136889 18607828
23. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. C Luxemburger F Nosten DE Kyle L Kiricharoen T Chongsuphajaisiddhi NJ White, Trans R Soc Trop Med Hyg 1998 92 45 49 10.1016/S0035-9203(98)90950-6 9692150 (Pubitemid 28073728)
24. Clinical malaria in African pregnant women. A Bardaji B Sigauque L Bruni C Romagosa S Sanz S Mabunda I Mandomando J Aponte E Sevene PL Alonso C Menendez, Malar J 2008 7 27 10.1186/1475-2875-7-27 18234078
25. Treatment of malaria restricted to laboratory-confirmed cases: a prospective cohort study in Ugandan children. D Njama-Meya TD Clark B Nzarubara S Staedke MR Kamya G Dorsey, Malar J 2007 6 7 10.1186/1475-2875-6-7 17239256
26. Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda. R Ndyomugyenyi P Magnussen S Clarke, Malar J 2007 6 39 10.1186/1475-2875-6-39 17407555
27. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. H Reyburn R Mbatia C Drakeley I Carneiro E Mwakasungula O Mwerinde K Saganda J Shao A Kitua R Olomi BM Greenwood CJ Whitty, BMJ 2004 329 1212 10.1136/bmj.38251.658229.55 15542534
28. Malaria case-management under artemether-lumefantrine treatment policy in Uganda. D Zurovac JK Tibenderana J Nankabirwa J Ssekitooleko JN Njogu JB Rwakimari S Meek A Talisuna RW Snow, Malar J 2008 7 181 10.1186/1475-2875-7-181 18803833
29. Drug procurement, the Global Fund and misguided competition policies. R Tren K Hess R Bate, Malar J 2009 8 305 10.1186/1475-2875-8-305 20028536
30. Disappearance of drugs undermines Uganda's fight against malaria. P Moszynski, BMJ 2010 340 2611 10.1136/bmj.c2611 20478964
31. Determinants of use of intermittent preventive treatment of malaria in pregnancy: Jinja, Uganda. LR Sangaré A Stergachis PE Brentlinger BA Richardson SG Staedke MS Kiwuwa NS Weiss, PLoS One 2010 5 15066 10.1371/journal.pone.0015066 21124732
32. Variation in malaria transmission intensity in seven sites throughout Uganda. PE Okello W Van Bortel AM Byaruhanga A Correwyn P Roelants A Talisuna U D'Alessandro M Coosemans, Am J Trop Med Hyg 2006 75 219 225 16896122 (Pubitemid 46941334)
33. Intensity of malaria transmission, antimalarial-drug use and resistance in Uganda: what is the relationship between these three factors? AO Talisuna P Langi N Bakyaita T Egwang TK Mutabingwa W Watkins E Van Marck U D'Alessandro, Trans R Soc Trop Med Hyg 2002 96 310 317 10.1016/S0035-9203(02)90108-2 12174786 (Pubitemid 34785072)
34. Roll Back Malaria Monitoring and Evaluation Reference Group, World Health Organization, United Nations Children's Fund, MEASURE DHS, MEASURE Evaluation, and U.S. Centers for Disease Control and Prevention, Malaria Indicator Survey: Basic documentation for survey design and implementation Calverton, Maryland: MEASURE Evaluation 2005
35. Uganda Demographic and Health Survey 2006. Uganda Bureau of Statistics Macro International Inc, Calverton, Maryland, USA: UBOS and Macro International Inc 2007
36. Antimalarial drug toxicity: a review. HO Alkadi, Chemotherapy 2007 53 385 391 10.1159/000109767 17934257 (Pubitemid 350085250)
37. Case management of malaria in pregnancy. F Nosten R McGready T Mutabingwa, Lancet Infect Dis 2007 7 118 125 10.1016/S1473-3099(07)70023-3 17251082 (Pubitemid 46137945)
38. Epidemiology of drug-resistant malaria. C Wongsrichanalai AL Pickard WH Wernsdorfer SR Meshnick, Lancet Infect Dis 2002 2 209 218 10.1016/S1473-3099(02) 00239-6 11937421 (Pubitemid 34464751)
39. Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. S Dellicour FO ter Kuile A Stergachis, PLoS Med 2008 5 187 10.1371/journal.pmed.0050187 18788893
40. The safety of artemisinins during pregnancy: a pressing question. S Dellicour S Hall D Chandramohan B Greenwood, Malar J 2007 6 15 10.1186/1475-2875-6-15 17300719
41. New medicines for tropical diseases in pregnancy: catch-22. NJ White RM McGready FH Nosten, PLoS Med 2008 5 133 10.1371/journal.pmed.0050133 18563964
42. A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy. R McGready EA Ashley E Moo T Cho M Barends R Hutagalung S Looareesuwan NJ White F Nosten, J Infect Dis 2005 192 846 853 10.1086/432551 16088834 (Pubitemid 41193082)
43. Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy. R McGready T Cho L Villegas A Brockman M van Vugt S Looareesuwan NJ White F Nosten, Tran R Soc Trop Med Hyg 2001 95 651 656 10.1016/S0035-9203(01)90106-3 (Pubitemid 34202258)
44. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 episodes of multidrug-resistant Plasmodium falciparum. R McGready T Cho NK Keo KL Thwai L Villegas S Looareesuwan NJ White F Nosten, Clin Infec tDis 2001 33 2009 2016 10.1086/324349 (Pubitemid 33152395)
45. World Health Organization, Assessment of the safety of artemisinin compounds in pregnancy. Report of two informal consultations convened by The Special Programme for Research and Training in Tropical Diseases (TDR) and The Global Malaria Programme of the World Health Organization (WHO) in 2006 Geneva, TDR/WHO, 2006 (WHO/CDS/MAL/20903.1094), (WHO/GMP/TDR/Artemisinin/07.1)
46. The safety of artemisinins during pregnancy: a pressing question. S Dellicour S Hall D Chandramohan B Greenwood, Malar J 2007 6 15 10.1186/1475-2875-6-15 17300719
47. ACT NOW to get malaria treatment that works to Africa. Médecins Sans Frontières. MSF Access to Essential Medicines Campaign, 2003
48. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. D Francis SL Nsobya A Talisuna A Yeka MR Kamya R Machekano C Dokomajilar PJ Rosenthal G Dorsey, J Infect Dis 2006 193 978 986 10.1086/500951 16518760
49. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. S Patrick Kachur J Schulden CA Goodman H Kassala BF Elling RA Khatib LM Causer S Mkikima S Abdulla PB Bloland, Trop Med Int Health 2006 11 441 451 10.1111/j.1365-3156.2006.01588.x 16553927
50. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. RD Newman ME Parise L Slutsker B Nahlen RW Steketee, Trop Med Int Health 2003 8 488 506 10.1046/j.1365-3156.2003.01066.x 12791054 (Pubitemid 36724013)
51. Improved diagnostic testing and malaria treatment practices in Zambia. DH Hamer M Ndhlovu D Zurovac M Fox K Yeboah-Antwi P Chanda N Sipilinyambe JL Simon RW Snow, JAMA 2007 297 2227 2231 10.1001/jama.297.20.2227 17519412 (Pubitemid 47010880)
52. Access to antimalarial therapy: accurate diagnosis is essential to achieving long term goals. H Hopkins C Asiimwe D Bell, BMJ 2009 339 2606 10.1136/bmj.b2606 19584113